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The present study is concerned with the isolation of poliomyelitis virus from 
human blood during the incubation period,  or early in the minor illness phase 
of infection. 
The search for virus in the blood of patients with poliomyelitis has been taken up 
periodically by investigators since 1909 (1).  Early efforts all yielded negative results, 
and  it was not until  1946  that  the first successful  isolation was reported from this 
laboratory (1). In 1949 a second isolation of virus from human blood was reported by 
Koprowski et al. (2). The single positive test obtained in our laboratory was with blood 
from a 9 year old girl, drawn within 6 hours from the onset of a minor illness or abor- 
tive attack of the disease.  Since it represented only 1 positive of 111 tested, we inferred 
that viremia occurred  rarely in  the human disease and was probably of  no  signifi- 
cance in its  pathogenesis.  Subsequently,  however,  it became apparent  that  by the 
time a clinical  diagnosis of poliomyelitis is made, the patient may already have anti- 
bodies to his own strain of poliomyelitis virus (3, 4), and perhaps even to a heterologous 
type (5).  Furthermore,  in primates infected by the oral route, antibodies were dem- 
onstrated  to be already present  by the  time paralysis occurs  (6).  It seemed likely, 
therefore, that in general, we,  as well as other investigators, had looked for viremia 
too late in the course of the human infection; i.e., after  the appearance of the 2nd 
phase,  or major illness,  and at a  time when instead of viremia,  one could expect to 
find antibodies.  It was decided, therefore, to reinvestigate the problem of viremia in 
poliomyelitis. 
At first, efforts were directed toward demonstrating viremia early in the course of 
experimental infection after a  natural route of transmission; i.e., orally, using chim- 
panzees and cynomdgus monkeys. It was found, in this laboratory (7) and by Bodian 
(8),  that virus can be isolated from the blood of these animals with some regularity 
several  days after its  ingestion,  and  it may persist  there  for as long as 5  days.  In 
cynomolgus monkeys, which became paralyzed after  feeding, viremia occurred rela- 
tively early in the incubation period and as long as 6 days before the onset of paralysis. 
In all animals showing viremia antibodies were prompt to  appear,  being present by 
the time signs of the experimental disease  developed. 
*Aided by a grant from The National  Foundation  for Infantile  Paralysis, Inc. 
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With these experimental results as a background,  the attempt to demonstrate 
viremia in the human  infection was  taken up once more in  1952.  Efforts were 
concentrated  not on frank  clinical cases occurring in  a  poliomyelitis epidemic 
but  on  contacts  of  a  known  patient  who  might  be  in  the  incubation  period, 
and on children showing the minor illness syndrome. Bodian and Paffenbarger 
(13) undertook a  similar investigation during the same summer,  and succeeded 
in isolating virus from the blood of 3  children.  A  preliminary report  covering 
some of our results has also appeared  (12). 
Materials and Methods 
A sharp outbreak of poliomyelitis which occurred in rural Ohio in 1952 was selected for 
study. Most of the cases occurred in small towns of several hundred to a thousand population, 
and in some of these extremely high attack rates were noted (9). 
Collection and Preservation of Specimens.--Between  June 20 and July 11, 1952, specimens 
were collected by one of us. x  The procedure  followed  was  that as soon as a patient was ad- 
mitted to a  hospital, or reported to the health officer, a  visit was made to the family and 
neighborhood contacts of the case.  Histories were taken and any child with symptoms was 
examined, and his temperature recorded. An effort was made to obtain a throat swab, a rectal 
swab, and 20 ml. of blood from all contacts, particularly those under 15 years of age, as well 
as from any non-contacts in the area who gave a history suggestive of the minor iUness syn- 
drome. In all, 119 blood specimens,  111 throat swabs,  and 83 rectal swabs were obtained. All 
but 6 individuals from whom specimens were collected were contacts of a known case. 
Throat and rectal swabs were placed in 1 ml. of 50 per cent sterile glycerine and frozen on 
dry ice shortly after collection. Blood was collected in vacutainer tubes containing potassium 
oxalate as anticoagulant.  The tubes of whole blood were centrifuged at 3000 R.P.~.  for 10 
minutes, thus layering the plasma, white cells, and red cells before freezing. All specimens were 
transported to New Haven in the frozen state, and kept frozen until tested for the presence 
of poliomyelitis virus. 
Testing of Specimens  for Poliomyelitis Virus. Bloods.--All were tested in tissue culture tubes, 
and a certain number were tested in rhesus monkeys (Macaca mulatta) by the intracerebral 
route. Approximately 0.6 ml. amounts of plasma,  or plasma and whole blood mixed, were 
inoculated into monkeys, 0.3 ml. being directed into the right and left sides of the thalamus. 
If the monkey failed to develop signs  of poliomyelitis, it was reinoculated with the same 
specimen 3 to 4 weeks after the first injection. Any animals showing signs suggestive of the 
disease were sacrificed  for histological study. The tissue culture techniques employed varied 
during the course of the work, always in efforts to make the tests more senstive. 
At first, monkey testiculax roller tubes were employed (10) usually 2 tubes being inoculated 
with plasma, and 2 with the sedimented red and white cell mixture containing some plasma; 
the red ceils had partially hemolyzed as a result of being frozen on dry ice and thawed. The 
inoculum was 0.1  ml. in 0.9 ml. of media. The cultures were examined microscopically at 4 
xWe are grateful for the cooperation and help given us by Dr. E. E. Kleinschmidt, then 
Health Commissioner of the Wayne and Medina General Health District, and to Dr. Frederick 
Wentworth, Chief of the Communicable Disease Division, Ohio State Department of Health 
and  their  staffs,  to Dr.[ James Kramer, Chief of  Staff,  Children's Hospital, Akron,  and  to 
Mr. Edward Tulley, Chairman of the Summit County Chapter  of The National Foundation 
for Infantile Paralysis. We are also indebted to Dr. Claude Reed, Miss Ilah  Kauffman,  and 
Mrs.  Berttina Orsborne,  for assistance in the collection of specimens. D.  M.  HORSTMAN'N', R.  W.  MCCOLLU'M[, AND  A.  D.  MASCOLA  ~57 
and 8 days at which time the fluid media was changed. Fluids from all positive or questionably 
positive tubes, i.e. those showing a cytopathogenic effect, were passed. The final reading was 
made on the 12th day; if no signs of degeneration had appeared,  the 8 and 12 day harvests 
were pooled and passed blindly to 2 to 4 testicular roller tubes. Subsequently a shift was made 
to the use of monkey kidney tubes, both roller and stationary (11). All blood specimens from 
individuals who were known to be infected, as evidenced by a positive throat and/or rectal 
swab, were retested in monkey kidney tubes, using 8 to 10 tubes per specimen, and passing 
blindly the 8 and 12 day harvests of negative specimens.  Finally, the remainders of a certain 
number  of specimens (usually less than 5  ml. in amount)  were ultracentrifuged  at 30,000 
g.P.~, for i  hour, and the sediment tested in 10 monkey kidney tubes. All positive specimens 
were retested, when possible, returning to the original specimen. 
Throat and Rectal Swabs.--These were prepared for inoculation by removing the cotton 
and squeezing it out thoroughly in 1 ml. of sterile saline. After light centrifugation, monkey 
testicular tubes were inoculated with 0.1 ml. of the suspension.  Two tubes were used for each 
specimen; they were examined microscopically at 4, 8, and  12 day intervals, and passed in 
the same manner as the tubes inoculated with blood. Subsequently, when the greater sensitivity 
of kidney tissue was appreciated, all negative specimens were retested in 4 to 6 monkey kidney 
tubes. 
NeuZralization Tests.--All strains isolated were typed by means of tissue culture neutraliza- 
tion tests, using either monkey testicle or monkey kidney tubes (I0). When kidney tubes were 
employed a high titer was obtained so rapidly that in order to avoid overdosing the system 
with virus, it was usually necessary to set up tenfold dilutions of the virus to be typed with 
hyperimmune monkey serum against Types 1, 2, and 3 poliomyelitis virus. Equal amounts 
of the unknown virus and hyperimmune serum diluted 1: 5 were arranged in a series of tubes. 
A control tube contained virus and balanced salt solution. The mixtures were incubated at 
room temperature for 1 hour before being inoculated into 2 tubes each. The tests were read 
at 4 and 8 days when testicular tubes were employed, and 2 and 4 days when kidney tubes 
were used. Complete inhibition of degeneration by serum of one type only was taken to in- 
dicate specific neutralization of the virus. 
Neutralization tests on the blood specimens collected were carried out in similar fashion, 
using equal amounts of a  1:5 dilution of plasma and I00 tissue culture doses of the standard 
Brunhilde Type 1 strain. 
RESULTS 
Isolation of Virus from the Blood.--Type  1  poliomyelitis virus  was  isolated 
from  the blood of 6  of 33  individuals  infected with  this  type as evidenced by 
positive  throat  and/or  rectal  swabs.  Blood  specimens,  throat,  and/or  rectal 
swabs  from the  other 86 individuals  tested  were all negative for poliomyelitis 
virus.  In the positive blood specimens,  the virus was present  in both plasma, 
and in the partially hemolyzed red and white cell mixtures which also contained 
some plasma3  Of the  6  with viremi~,  throat  and  rectal  swabs  were available 
from 5, and throat swab alone from one; all these specimens also yielded Type 
*An effort to determine with which fraction of the blood the virus is associated was sub- 
sequently carried out using blood from a cynomolgus monkey with viremia after ingestion of 
a  Type 1 strain of virus (16).  No significant difference in titer was detected among serum, 
plasma,  and  sedimented red and white cell mixtures containing some plasma; however, no 
virus was found in association with the thoroughly washed red cells. Washed white cells alone 
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1 poliomyelitis virus.  The  clinical and epideraiological circumstances under 
which viremia was detected in the 6 individuals were various. 
Four of the positive blood specimens were obtained from 4  children in one family, the 
W. family, residing in Burbank, a town of approximately 400 inhabitants which had a high 
attack rate. The family had had no known contact with a ease of poliomyelitis, but at the 
time specimens were collected, on ]une 23, 3 of the children had symptoms suggestive of the 
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Fro.  1.  An outbreak of Type  1 poliomyelitis infection  in the W.  family. Shaded areas 
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of Type 1 virus from blood (BI), throat swab (T), and rectal swab (R). 
minor illness and one was asymptomatic  (Fig.  1).  The father had complained of headache 
several days previously, but there were no associated symptoms; the mother remained well 
throughout. B.W., age 10 years, had an onset with sore throat, fever, and anorexia, beginning 
on June 20. She complained also of soreness  of the calves of the legs. On June 23, the day 
on which specimens were collected, her rectal temperature was 101.2°F.  W.W., age 4 years, 
had her first symptoms on June 22, beginning with fever and vomiting. On June 23 her throat 
was sore, tonsils appeared enlarged and red;  the  rectal  temperature was 102°F. D.W. age 3 
years, began with fever, nausea, and vomiting on June 21. His temperature  on June 23 was 
99.5°F., and there were no physical signs.  Be.W, age 2 years,  remained asymptomatic.  Her 
rectal temperature on June 23 was 99.5°F. D.  M.  I:IORSTMANN~ R.  W.  M'CCOLL13~ AND  A.  D.  M-ASCOLA  359 
The children recovered promptly, and when a  follow-up visit was made on June 25, all 4 
were well and outdoors playing. Fig. 1 illustrates diagrammatically the course of events in 
the family, and the time at which the positive specimens were obtained. Tests for Type 1 
antibody in the blood of the 4 children made at the time of viremia were all negative. 
Viremia was also detected in an infant who subsequently  developed mild non-paralytic 
poliomyelitis: N.A., aged 10 months, was a household contact of a 5 year old girl who had been 
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Fro. 2. Type 1 poliomyelitis virus infection in the A. family, and two neighborhood contacts. 
Legends as in Fig. 1. T  +  A indicates tonsillectomy +  adenoidectomy; Hosp., hospitalized; 
N.P.P., non-paralytic poliomyelitis. AB Jr or --, Type 1 neutralizing antibodies positive or 
negative. 
admitted to the hospital on June 18 with a diagnosis of bulbar poliomyelitis (Fig. 2). He was 
well until about June 14, when he developed a "cold;" i.e., cough and runny nose, which per- 
sisted for about 8 days and was present on June  21 when  throat  and  rectal  swabs, and a 
blood specimen were collected. By June 22, the child seemed well, and remained so until June 
24, when he developed fever, which persisted over the next 4 days, the maximum temperature 
being 102°F.  During this time he was drowsy, slept a great deal, and vomited occasionally. 
On June 27 he was admitted to the hospital at which time his temperature was found to be 
101.2°F.,  and physical examination revealed an ;nflAmed pharynx and tonsils, and moderate 
anterior cervical adenopathy. The neck was supple. Spinal puncture, however, yielded fluid 
containing 22 W-BC per c. ml., with 60 per cent lymphocytes, and a positive test for globulin. 
His recovery was uneventful; muscle examination on July 3 revealed slight tightness of neck 360  VII~MIA IN POLIOMYELITIS 
and back muscles, lie was discharged as well on July 10. As indicated in Fig. 2, poliomyelitis 
virus was isolated from all three specimens taken on June 21 from N.A., --blood, throat swab, 
and rectal swab. This was 3 days before the onset of the major illness, which in his case turned 
out to be mild non-paralytic poliomyelitis. At the time the specimens were collected just 
prior to the "second phase" of his illness he was afebrile, although he still had a "cold" which 
had been present for 8 days. 
Fig. 2, which is concerned with the A. family and two contacts of the chil- 
dren,  shows  the  time relationships of symptoms in  the  group,  as well as the 
results of tests for virus in blood, throat, and rectal swabs, and Type 1 antibody 
determinations  on  the  blood specimens.  All 4  children who  were  contacts  of 
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FIG. 3. Type 1 poliomyelitis infection in the L. family. Legends as in Fig. 1. Par. Polio., 
paralytic poliomyelitis. 
the  index  case,  2  familial and  2  extrafamilial, were  infected,  and  all but  1 
(N.A.)  from whose  blood poliomyelitis virus was  isolated, had  antibodies to 
Type  1  virus.  The  time from  onset  of  the  minor illness to  the  collection of 
specimens was  10,  5,  and S  days respectively in  those positive for antibodies 
but negative for viremia, or 8, 2, and 2 days after the minor illness symptoms 
had disappeared. 
The 6th virus isolation from blood, was from W.L., an asymptomatic 15 year old boy, a 
household contact of a 4 year old paralytic case whose onset date was June 28 (Fig. 3). W.L. 
gave a history of "a mild cold" on June 22, which apparently lasted 1 day and cleared com- 
pletely. He was well on July 1 when a throat swab and blood specimen were collected, both 
of which yielded Type 1 poliomyelitis  virus. No virus was isolated from the 2 other siblings, 
one of whom, age 10 years, had Type 1 neutralizing  antibodies. Don. L., age 16, gave a history D.  M.  HORSTMANN~ R.  W.  MCCOLLITM) A~N'D A.  D.  MASCOLA  361 
suggestive of a  minor illness, but she was negative for both virus and antibodies on July 1. 
That her illness was not poliomyelitis is suggested by the fact that her blood was negative for 
Type  1 poliomyelitis antibodies in March 1953, 9 months later. 
The strain of virus isolated from the blood of W.L.  behaved peculiarly in its 
early  passages.  Subsequently  it was  found  that  antibodies were  present  in  a 
titer  of  1:100  in  the  same  specimen  from  which  virus was  isolated.  The  cir- 
cumstances under which the isolation was made were as follows: 
The  plasma  and  hemolyzed red  cell  suspension were  inoculated  separately  in  0.I  ml. 
amounts into monkey testicular tissue culture tubes containing 0.9 ml. of media. After 4 days, 
the fluids were removed and discarded, and I ml. of fresh media was added to each tube. 8 days 
after inoculation the tubes showed no degeneration on microscopic examinations; the fluids 
were harvested and replaced with fresh media. At 12 days, still no degeneration was seen in 
the fibroblastic outgrowth; the fluids were therefore harvested, pooled with the 8 day harvests, 
and passed blindly. It is not possible to calculate accurately the  dilution  of  the  original 
specimen in the final harvest, but it was at least greater than I : 1000.  On blind passage to 2 
testicular tissue culture tubes, degeneration began to appear in both tubes by the 4th day, but 
was still not complete by the 8th day when the fluids were harvested. A  2nd blind passage 
was made from the original passage and this resulted in a 44- degeneration in I  of 4 tubes. 
3rd passage of both of these lines resulted in degeneration in all tubes, less coarse in type than 
usually seen with poliomyelitis virus. The titer of the two 3rd passages was low,  less than 
10  -'I. Two rkesus monkeys inoculated with undiluted 2nd and 3rd passage fluids failed  to 
develop any signs of poliomyelitis. Attempts to neutralize the 3rd passage with antisera to 
the 3 types gave unsatisfactory results because of the low titer of the virus. After a 4th passage 
in testicular tubes a shift was made to monkey kidney tissue culture tubes; and after 4 rapid 
passages, each showingdegeneration characteristic for poliomyelitis, a titerof 10  -~ was achieved. 
In a  neutralization test set up against the 3  types of hyperimmune serum using I00 tissue 
culture doses of virus, Type  I  antiserum completely inhibited virus growth, while Types 2 
and 3 serum had no effect. Undiluted 9th passage virus produced paralytic poliomyelitis in 
one monkey, and non-paralytic disease in another, both results being verified by histological 
examination. Attempts to repeat the isolation of virus from the blood of W.L.  were made, 
using monkey kidney tubes, and undiluted and diluted blood and plasma. All these efforts 
produced negative results. It may be said therefore that the strain of virus which was isolated 
was obtained with difficulty. 
In contrast, the strain of virus isolated from the throat of this same patient, behaved in 
a  more regular  fashion. It was negative in  2  testicular  tubes, but produced  characteristic 
degeneration in 7 of I0 kidney tubes on Ist passage, 4 of 4 on 2nd passage, and was completely 
neutralized by Type I antiserum on 3rd passage, its titer being 10  -~.5. A second trial in kidney 
tubes resulted in a  similar series of positive passages. Two rhesus monkeys, given undiluted 
2nd passage material, developed paralytic poliomyelitis. 
When both the original specimen, and a  follow-up blood sample from W.L.,  collected in 
March 1953, 9 months after the original specimen was obtained were titered for Type i  neu- 
tralizing antibodies in the same test, the  original had  a  titer of I: I00, and the later one a 
titer of greater than ] :500, suggesting that the first specimen was taken at a time when the 
titer was rising. 
Amounts  of  Virus  Present  in  the  Positive  Blood  Specimens.--As  Table  I 
indicates,  the virus isolations from blood were made with some difficulty.  The 362  VIP.XMIA IN POLIOMYELITIS 
TABLE I 
, The IsolaHon of Type 1 Poliomyelitis Virus from the Blood, Throat, and Rectal Swabs of 
6 Children 
Name  Age 
Date of  Date 
onset  speci-  Direct 
minor  men  mort- 
col-  I. key  illness  leered 
,inocu- 
lation 
B.W.  10 yrs.  6/20/52 6/23/52  Blood  0/1"  2/3t 
o/3U 
Throat swab  2/2 
Rectal swab  I/2 
W.W.  4 yrs.  6/22/52 6/23/52  Blood  0/2  0/4 
3/5 
1/3 
Throat swab  2/2 
Rectal swab  2/2 
D.W,  3 yrs.  6/21/52 6/23/52  Blood  0/2 
Throat swab 
Rectal swab 
Be.W.  2 yrs.  --  6/23/52  Blood  0/2 
Throat swab 
Rectal swab 
N.A.  10 mos. 
W.L.  15 yrs. 
76/14/52 6/21/52  Blood  0/2 
Throat swab 
Rectal swab 
Ist 
Results of tests for poliomyelitis  virus 
Tissue culture passage 
2nd  3rd  Later 
4/4  2/2§ 
2/2  2/2§ 
2/2  2/2§ 
0/2 
3/3  2/2§ 
~/2 
2/2  2/2§ 
2/2  2/2§ 
0/4  o/2 
0/4  o/3 
0/s  1/s  z/2§ 
3/10K¶  2/2§K 
4/4  2/2§ 
2/2  12/2  2/2§ 
0/4  0/2  ~/2 
0/4  i0/4 
1/6  15/6 
9/10§K*"  12/2K 
2/2  2/2  2/2§ 
2/2  2/2  2/2§ 
0/6 
0/5 
1/8K** 
4/4 
2/2 
?6/22/52 7/ 1/52  Blood  0/2  0/4 
Throat swab 
014 
0/10K 
0/10K 
0/10K** 
0/2 
7/lOK 
4/5K 
Monkey 
inoculation, 
tissue 
culture 
passage 
1/1(3rd) 
t/l(3rd) 
I/I (3rd) 
1/l(3rd) 
0/2 
i0/4 
5/5K  2/2§K  l/l(3rd) 
i2/2  i2/2§ 
2/2  ~/2§  ..... 
2/2  ~/4  2/2§K(9th)  0/2(2nd, 3rd) 
2/4  ~/2  2/2(9th) 
0/7K 
71/7K  )/4K 
o/8K 
0/2 
4/4K  2/2§K  2/2(2nd) 
4/4K  2/2§K 
* Numerator indicates number positive; denominator, number tested. 
Numerator indicates number of tubes showing degeneration; denominator, number of tubes inoculated. 
§ Neutralization by Type 1 antiserum. 
[] These monkeys received 0.3 intracerebrally once only. 
¶ K indicates monkey kidney  tissue culture tubes used, if no K is marked, monkey testlcular tubes were used. 
** Specimens uitracentrifuged before testing in monkey kidney tubes. 
quantity  of virus present  must have been minimal, for it was insufficient to 
produce  poliomyelitis in  rhesus  monkeys on  direct  intracerebral  inoculation 
of the  undiluted  plasma,  although  after passage in  tissue  culture,  the  speci- D.  M.  HORSTMANN,  R.  W.  McCOLLUM,  AND  A.  D.M.ASCOLA  363 
mens tested in monkeys produced typical poliomyelitis. Only 2 of the 6 speci- 
mens were positive on the first trial in monkey testicular tissue culture tubes, 
one (W.L.) only on blind passage; with the others several separate tests were 
carried out before positive results were obtained. 1st passages were often diffi- 
cult to interpret because of the tendency of certain plasma specimens to pro- 
duce non-specific toxic effects particularly in testicular tissue tubes; on 2nd 
passage, however, degeneration typical for poliomyelitis occurred, and neutral- 
ization tests demonstrated the agents to be Type 1 poliomyelitis virus. Kidney 
tissue  tubes proved  more  sensitive  in  detecting virus  than  testicular  tissue 
tubes, and some specimens which were negative or only suggestively positive 
on 1st passage with the latter, were clearly positive on 1st passage in kidney 
TABLE  II 
Results  of Tests for  Viremia  in Blood Specimens  of 119 Individuals  in an Epidemic Area* 
Group 1--33 persons with positive throat  Group 2--78 persons  ~roup 3-8 persons 
and/or rectal swab  with negative throat  throat and rectal 
Age  and/or rectal swab  swabs not tested 
Antibody --  Antibody q-  Anti-  Anti-  body -  body -[- 
~tt$. 
0-4 
5-9 
10-14 
15-19 
20+ 
totals... 
4/s5 
o/2 
1/3 
o/1 
t  5/14 
(36 per cent) 
0/8 
0/5 
0/5 
1/t 
1/19 
(5 per cent) 
Anti-  Anti- 
body--  b~y+ 
o/8  o/1o 
0/4  o/1s 
0/5  0/19 
0/6  o/5 
0/3  0/3 
0/26  0/52 
o/I 
o/i 
0/2 
0/1 
o/i 
0/4 
0/6 
* All strains isolated from blood, throat, and rectal swabs belonged  to Type 1.  Antibody 
status refers to Type 1 neutralizing antibodies. 
Numerator, number positive for viremia; denominator, number tested. 
tubes. Ultracentrifugation also probably aided in increasing the sensitivity of 
the tests; one specimen (N.A.) which had been negative on direct inoculation 
of testicular tissue tubes, after ultracentrifugation was positive in kidney tubes. 
The Incidence of Viremia in the Group Studied.--In all, 6 blood specimens 
from 33  individuals known to be infected, yielded virus. The question arose 
whether the negative results might be due to the blood having been drawn too 
late in the course of infection, at a time when antibodies were already present, 
since, ordinarily, in spite of the instance of viremia in the presence of anti- 
bodies reported above, one would not expect to find circulating virus in the 
presence of specific  antibodies. 
The blood specimens of the 33 infected individuals, as well as those of the 
86 from whom no virus was isolated, were, therefore, all tested for the presence 
of Type 1 neutralizing antibodies. The results are shown in Tables II and III. 364  VIREMIA  IN  POLIOMYELITIS 
Table  II  relates viremia to the antibody status  and age  of the individuals 
tested. In group 1,  consisting of the 33 individuals known to be infected with 
Type 1 virus, viremia was detected in 5 of 14 who were bled early enough in the 
course of infection to be without antibody levels sufficient to neutralize  100 
tissue culture doses of virus. Of the 19 infected individuals who had detectable 
Type  1 antibodies,  1 was found to have virus in the blood as noted above. 
No virus was isolated from the blood of the 78 non-infected individuals, 26 of 
whom were antibody-negative, and 52 antibody-positive, nor from the 8 from 
whom only blood specimens were collected. 
DISCUSSION 
In these studies poliomyelitis virus has been demonstrated in human blood 
in association with three types of infection: the minor illness,  the asympto- 
matic infection, and preceding the non-paralytic form of the disease.  As  to 
how commonly viremia occurs in the human infection, one cannot say, but the 
fact that it was found in 5 of 14 individuals who were bled early enough in the 
course of infection to be without antibodies, suggests that it may occur with 
some frequency (Table II). 
The finding of virus in the blood of children with the minor illness confirms 
the earlier observation from this laboratory (1),  and is in line with Bodian 
and Paffenbarger's recent results  (13);  it would seem to establish beyond a 
doubt that the minor illness--or first phase of the diphasic cause -is a specific 
infection with poliomyelitis virus, and not merely a non-specific and unrelated 
disease which precipitates poliomyelitis, a  view which is sometimes still put 
forth (14).  The speed with which antibodies appeared after the minor illness 
in some of the children in this study also supports the specificity of the syn- 
drome. In recent years antibodies have been demonstrated to be present at the 
time of onset of the 2nd phase or major illness (3, 4), and also as early as 9 
days after the minor illness (15); the present findings indicate that they may 
appear even earlier--as soon as 3 and 4 days after the onset of the minor ill- 
ness (Fig. 2, Table III). 
Two striking features of viremia in orally infected monkeys and chimpanzees 
are first, its early appearance--as  soon as 3 or 4  days (occasionally only 24 
hours) after virus ingestion, and as long as a week before paralysis (16); and 
second, its constant association with the early appearance of antibodies. The 
time at which viremia has been demonstrated in human poliomyelitic infection 
agrees well with the pattern found in orally infected animals. Two instances of 
viremia have, however, been reported, by Koprowski a  al.  (2) and Jungeblut 
(17)  in which virus was detected after the onset of the major illness.  One can 
speculate that in these individuals antibody-producing mechanisms were slow 
in responding, and antibodies failed to appear as they usually do, by the time 
of onset of symptoms. Jungeblut has suggested that in his patient, the fact D.  M.  HORSTMANN,  R.  W.  McCOLLUM~  AND  A.  D.  MASCOLA  365 
that  she was pregnant at  the  time of infection, may have involved adrenal 
mechanisms, so that the situation was analogous to poliomyelitis with viremia 
induced in hamsters by the administration of ACTH or cortisone as reported 
by Schwartzman (18). 
TABLE  HI 
Type 1 Poliomyelitis Viruz Isolations and Neutralizing Antibody Status of 33 Infected 
Indivlduals 
Group 1--With  symptoms  [I  Group 2--Asymptomat|c 
Name 
B.W. 
W.W. 
D.W. 
N.A. 
W.L. 
B.S. 
D.S. 
J.K. 
M.C.¶ 
M.C.¶ 
D.J. 
L.S. 
K.A. 
K.L. 
L.Z. 
B.R. 
D.R. 
G.H. 
Age  History 
S.t.§,  fever,  headache. 
anorexia,  3 days 
Fever, vomiting, S.t., 
day 
2 days 
"Cold," 8 days 
"Cold," 1 day 
S.t.,  abdominal  pain, 
day 
2 days 
1 day 
Vomiting,  1 day 
Vomiting,  fever,  1 day 
"Cold," 1 day 
S.t.,/ever, 3 days 
Fever, 1 day 
Headache,  fever,  1 day 
Headache,  fever,  1 day 
S.t., fever,  1 day 
Fever, "several days" 
Cough,  conjunctivitis,  7 
days 
Results of 
virus testM: 
T  R  B1 
3 
1 
2 
8 
9  1~  n 
3 
2  i 
4 
6 
,II 
13 
s  r 
31 ++-+ 
4  -{-  -P  -- 
+  l~  + 
7  O--  -b  -- 
I 
Age 
Results of  T~I 
virus tests  anti- 
body 
T  R  BI  sta-  tus 
- 
+ 
-  + 
;  ÷  + 
+  + 
;  ÷  ÷ 
;  ÷  + 
* Refers to onset of symptoms compatible with the minor illness. 
$ T, R, B1, indicate  throat swab, rectal swab, and blood. 
§ S.t., sore throat. 
[l ND, not done, 
¶ These two children  developed mild non-paralytic poliomyelitis  2 days after the specimens were collected. 
The direct evidence that viremia in humans is followed by a  prompt anti- 
body response  consists  of Bodian  and  Paffenbarger's demonstration  that  3 
children from whose blood virus was isolated during the minor illness all had 
significant antibody titers 2 weeks later (13). Further, 1 individual in the pres- 
ent study  (W.L.) appears to have been bled at the moment  that  virus  was 
disappearing and antibody was appearing. Both the early appearance of virus 366  VIR~M.IA  IN  POLIOMYELITIS 
in the blood, and the early appearance of antibodies, support the earlier hypoth- 
eses of primary extraneural growth of poliomyelitis virus (19-21),  for it has 
been observed that when virus is growing only in nervous tissue, as presumably 
may happen after intracerebral inoculation of monkeys, antibody production 
may be long delayed (22-24). It seems likely that the very tissues responsible 
for antibody production may be the ones in which the virus may first multiply. 
Diffuse involvement of lymphoid tissue in the intestinal tract and in peripheral 
lymph nodes in the rapidly fatal human disease has been commented upon 
regularly since 1912 (25); and vires has been isolated from various lymph nodes 
with some frequency (25); the latter is especially striking if one considers that 
the tissues for testing were obtained at a time when antibodies were undoubt- 
edly present. Faber and his colleagues have shown that virus multiplication 
may appear very early in the peripheral ganglia in cynomolgus  monkeys in- 
fected orally (27). Multiplication in these sites does not, however, preclude its 
occurring in other and non-neural sites. 
The relationship of viremia to CNS invasion is uncertain. It may be as we 
assumed in 1946 (1), and as Faber et al. suggested recently (28), that it repre- 
sents simply a  spill-over from areas of active multiplication, and has no sig- 
nificance in the pathogenesis of the disease. The latter authors hold firm to the 
concept that poliomyelitis virus is a strictly neurotropic agent. On the other 
hand,  experimental poliomyelitis  can be produced in  the absence of intact 
nervous connections (29); and experiments of Bodian have shown the effective- 
ness of small amounts of passive antibody in protecting orally infected cynomok 
gus  monkeys  (8)  and  chimpanzees  (30)  against  the  development of  CNS 
lesions, presumably by preventing viremia. Both these observations suggest 
that the appearance of virus in the blood stream may be vital in the patho- 
genesis of the disease. This is the interpretation which was proposed in 1917 
by Draper (31) who pointed to the biphasic clinical course of poliomyelitis as 
evidence of a preliminary systemic or general infection, followed by the 2nd 
or CNS phase only when penetration of the blood brain barrier occurred. 
The time at which poliomyelitis  virus has been isolated from the blood, throat, 
and feces of patients, and the time at which antibodies have been found are 
indicated in Fig. 4, which is a schematic diagram of the so called "childhood 
type" of the disease (32). The findings suggest the following sequence of events 
as a likely possibility in the human biphasic infection: first, primary multiplica- 
tion of virus, occurring during the few days after exposure.  Such multiplica- 
tlon may be largely or entirely extraneural at this stage; second, the develop- 
ment of the "minor illness" in association with the presence of virus in blood, 
throat, and feces, with viremia persisting only for a few days, until antibodies 
make their appearance; finally, if the circulating virus has gained a foothold 
in the CNS,  a  neural phase of multiplication, followed by the characteristic 
signs  of CNS  involvement. A  similar interpretation of the pathogenesis of D.  M.  HORSTMAN~  R.  W'.  MCCOLLUM,  AND  A.  D.  MASCOLA  367 
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poliomyelitis has been suggested by Bodian, who designates the three hypothe- 
tical phases as visceral, viremic, and neural (33),  and by Pette (34); although 
there is  considerable evidence to  support  this  concept, it has  not yet been 
proven. 
The  Isolation  of Virus from  the Blood in  the Presence of Antibodies.--The 
finding of Type 1 virus in the blood of W.L., which also had Type 1 neutraliz- 
ing antibodies was unexpected. However, although a  laboratory error cannot 
be completely ruled out, on careful evaluation, there was no reason to suspect 
that any error had been made, especially inasmuch as none of the other 32 
specimens in the same test was positive, either originally or on blind passage. 
Furthermore, the peculiar behavior of the virus isolated supports the theory 
that the agent was in a modified, and atypical state, which is a  situation de- 
serving further study. Failure to repeat the isolation may be due in part to the 
time which elapsed between the 1st and only successful test in tissue culture 
which was set up 6 days after the specimen was collected, and the 2nd and 
subsequent attempts at isolation begun after the specimen had been kept frozen 
at  --20°C. for 6 months. 
The  isolation of infective particles from presumably neutralized mixtures 
of  antiserum  and  virus  is  a  well  known  phenomenon  with  other  systems. 
Vaccinia virus has been thoroughly studied in this respect, and it was found 
by Andrewes that the virus can be recovered even in the presence of an excess 
of antibody by simple dilution (35).  Coxsackie virus, which is in the same size 
range and has many biological and physical properties in common with polio- 
myelitis virus, can also be dissociated from its antibody by dilution, as shown 
by Melnick and Ledinko (36).  Since  the nature of the union of poliomyelitis 
virus and its antibody is unknown, one can only speculate as to the intimacy 
of the combination and the difficulty or ease with which it can be separated. 
SUMMARY 
Poliomyelitis virus was isolated from the blood of 6 of 33 individuals infected 
with a Type 1 strain. Of the 27 negative for viremia, 18 already had Type 1 
antibodies. 
Type 1 virus was isolated from the throat swabs of all 6 who had viremia, 
and from the 5 rectal swabs tested. These specimens were all collected at the 
same time as the positive blood specimens. 
The clinical circumstances under which viremia was detected included the 
minor illness,  the asymptomatic infection, and one instance in which the virus 
was isolated several days before the onset of a mild non-paralytic attack. 
In one instance, virus was isolated from a  blood specimen which also con- 
tained Type 1 antibodies. 
The possible role of viremia in the pathogenesis of poliomyelitis is discussed. D.  M.  HORSTMANN, R.  W.  McCOLLUM, AND A.  D.  MASCOLA  369 
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